Cite
The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.
MLA
Iacobone, Anna D., et al. “The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.” American Journal of Clinical Pathology, vol. 157, no. 1, Jan. 2022, pp. 130–35. EBSCOhost, https://doi.org/10.1093/ajcp/aqab103.
APA
Iacobone, A. D., Bottari, F., Guerrieri, M. E., Vidal Urbinati, A. M., Ghioni, M., Spolti, N., Pino, I., Passerini, R., Di Pace, R. C., Franchi, D., & Preti, E. P. (2022). The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening. American Journal of Clinical Pathology, 157(1), 130–135. https://doi.org/10.1093/ajcp/aqab103
Chicago
Iacobone, Anna D, Fabio Bottari, Maria E Guerrieri, Ailyn M Vidal Urbinati, Mariacristina Ghioni, Noemi Spolti, Ida Pino, et al. 2022. “The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.” American Journal of Clinical Pathology 157 (1): 130–35. doi:10.1093/ajcp/aqab103.